JKT · SRAJ.JK
PT Sejahteraraya Anugrahjaya Tbk
IDR 10,850-IDR 125 (-1.14%)
PT Sejahteraraya Anugrahjaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.49% below the high.
Loading market information…
JKT · PRDA.JK · IDR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:06 AM UTC. Cached market data; not a live quote.
One-year closing-price history · IDR. Historical prices are not a forecast.
PT Prodia Widyahusada Tbk’s quoted price sits in the upper half of its reported 52-week range, 4.26% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
PT Prodia Widyahusada Tbk’s forward annual dividend is IDR 163 per share, paid annual. The forward yield is 4.52% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
PT Prodia Widyahusada Tbk’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow PT Prodia Widyahusada Tbk’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PT Prodia Widyahusada Tbk provides clinical laboratory services in Indonesia. The company offers test services, such as genomic, laboratory, and non-laboratory tests, as well as test panels; doctor consultation and teleconsultation services; vaccines; home services; and research support services. It also engages in the operation of Prodia Health Care, a personalized medicine-based wellness clinic; and specialty clinics, including Prodia Children, Prodia Women, and Prodia Senior. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk operates as a subsidiary of PT Prodia Utama.
Latest available per-share figures in IDR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| IDR 486.85B |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
IDR 10,850-IDR 125 (-1.14%)
PT Sejahteraraya Anugrahjaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.49% below the high.
IDR 730+IDR 15 (+2.1%)
PT Kalbe Farma Tbk.’s quoted price sits in the lower half of its reported 52-week range, 45.52% below the high.
IDR 1,880-IDR 20 (-1.05%)
PT Siloam International Hospitals Tbk’s quoted price sits in the lower half of its reported 52-week range, 34.72% below the high.
IDR 1,310-IDR 60 (-4.38%)
PT Mitra Keluarga Karyasehat Tbk’s quoted price sits in the lower half of its reported 52-week range, 51.66% below the high.
IDR 1,100-IDR 60 (-5.17%)
PT SOHO Global Health Tbk.’s quoted price sits in the lower half of its reported 52-week range, 72.57% below the high.
IDR 378+IDR 42 (+12.5%)
PT Metro Healthcare Indonesia Tbk’s quoted price sits in the lower half of its reported 52-week range, 60.83% below the high.
IDR 2,410-IDR 80 (-3.21%)
PT Tempo Scan Pacific Tbk’s quoted price sits in the lower half of its reported 52-week range, 25.16% below the high.
IDR 278-IDR 2 (-0.71%)
PT Diagnos Laboratorium Utama Tbk’s quoted price sits in the upper half of its reported 52-week range, 27.23% below the high.
